Wheeze in the time of COVID-19: overcoming obstacles to an unusual diagnosis
- PMID: 35768197
- DOI: 10.1136/thoraxjnl-2021-218526
Wheeze in the time of COVID-19: overcoming obstacles to an unusual diagnosis
Abstract
This case is an example of a rare cause of a common clinical presentation (persistent lobar collapse with wheeze). We describe patient management from primary care through to a national thoracic referral centre. We highlight the importance of objective testing to support an asthma diagnosis and the need to consider alternative or additional diagnoses if a patient does not respond to treatment or the clinical course is unexpected. We highlight the importance of follow-up X-ray to determine whether atelectasis has resolved, which was significantly delayed in this case due to COVID-19 restrictions. Though rare, an endobronchial tumour should be considered if atelectasis persists and when planning endoscopy for a presumed foreign body, especially if the clinical history and patient factors make a foreign body less likely. Greater awareness of this as a differential may expedite diagnoses for patients in future. We show how virtual, multicentre, multidisciplinary meetings can aid rapid diagnosis, surgical planning and coordination of follow-up across centres.
Keywords: Bronchoscopy; COVID-19; Histology/Cytology; Paediatric Lung Disaese; Paediatric asthma; Rare lung diseases; Thoracic Surgery.
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: ARS reports grants and speaker honoraria from Vertex as well as expenses and personal fees from Vertex, outside the submitted work. In addition, ARS has a patent issued 'alkyl quinolones as biomarkers of Pseudomonas aeruginosa infection and uses thereof'. The other authors had no competing interests to declare.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical